Barrowcliffe Susan E.
General Manager, Europe at Aimmune Therapeutics, Inc.
- Sold, on record
- $6.1M
- Dollars the filings state
- Form 4 sales
- 9
- Latest Nov 19, 2018
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Aimmune Therapeutics, Inc.General Manager, Europe
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Aimmune Therapeutics, Inc.UnusualNov 11, 2016 2016
Sold 20,000 shares at $25.00 ($500k)
Barrowcliffe Susan E., General Manager, Europe
Sold 100% of holdings ($500k position)0 shares leftFiling
- 2 Form 4 sale Aimmune Therapeutics, Inc.UnusualJul 3, 2017 +234 days
Sold 15,000 shares at $20.26 ($304k)
Barrowcliffe Susan E., General Manager, Europe
Sold 100% of holdings ($304k position)0 shares leftFiling
- 3 Form 4 sale Aimmune Therapeutics, Inc.UnusualJul 25, 2017 +22 days
Sold 6,110 shares at $22.00 ($134k)
Barrowcliffe Susan E., General Manager, Europe
Sold 100% of holdings ($134k position)0 shares left0.4x usual sizeFiling
- 4 Form 4 sale Aimmune Therapeutics, Inc.UnusualJul 27, 2017 +2 days
Sold 500 shares at $22.00 ($11k)
Barrowcliffe Susan E., General Manager, Europe
Sold 100% of holdings ($11k position)0 shares left0x usual sizeFiling
- 5 Form 4 sale Aimmune Therapeutics, Inc.UnusualSep 6, 2017 +41 days
Sold 18,390 shares at $22.00 ($405k)
Barrowcliffe Susan E., General Manager, Europe
Sold 100% of holdings ($405k position)0 shares left1.2x usual sizeFiling
- 6 Form 4 sale Aimmune Therapeutics, Inc.UnusualSep 25, 2017 +19 days
Sold 20,000 shares at $25.00 ($500k)
Barrowcliffe Susan E., General Manager, Europe
Sold 100% of holdings ($500k position)0 shares left1.3x usual sizeFiling
- 7 Form 4 sale Aimmune Therapeutics, Inc.UnusualJan 2, 2018 +99 days
Sold 75,000 shares at $37.14 ($2.8M)
Barrowcliffe Susan E., General Manager, Europe
Sold 100% of holdings ($2.8M position)0 shares left5x usual sizeFiling
- 8 Form 4 sale Aimmune Therapeutics, Inc.UnusualNov 19, 2018 +321 days
Sold 40,000 shares at $30.04 ($1.2M)
Barrowcliffe Susan E., General Manager, Europe
Sold 81% of holdings ($1.5M position)9,375 shares left2.4x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (9)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Nov 19, 2018 | Nov 21, 2018 | Aimmune Therapeutics, Inc. | General Manager, Europe | Form 4 sale | 40,000 | $1.2M | 81.0% | Unusual | SEC |
| Jan 2, 2018 | Jan 4, 2018 | Aimmune Therapeutics, Inc. | General Manager, Europe | Form 4 sale | 75,000 | $2.8M | 100.0% | Unusual | SEC |
| Sep 25, 2017 | Sep 27, 2017 | Aimmune Therapeutics, Inc. | General Manager, Europe | Form 4 sale | 20,000 | $500k | 100.0% | Unusual | SEC |
| Sep 6, 2017 | Sep 7, 2017 | Aimmune Therapeutics, Inc. | General Manager, Europe | Form 4 sale | 18,390 | $405k | 100.0% | Unusual | SEC |
| Jul 27, 2017 | Jul 31, 2017 | Aimmune Therapeutics, Inc. | General Manager, Europe | Form 4 sale | 500 | $11k | 100.0% | Unusual | SEC |
| Jul 25, 2017 | Jul 25, 2017 | Aimmune Therapeutics, Inc. | General Manager, Europe | Form 4 sale | 6,110 | $134k | 100.0% | Unusual | SEC |
| Jul 3, 2017 | Jul 6, 2017 | Aimmune Therapeutics, Inc. | General Manager, Europe | Form 4 sale | 15,000 | $304k | 100.0% | Unusual | SEC |
| Nov 11, 2016 | Nov 15, 2016 | Aimmune Therapeutics, Inc. | General Manager, Europe | Form 4 sale | 20,000 | $500k | 100.0% | Unusual | SEC |
| Nov 8, 2016 | Nov 10, 2016 | Aimmune Therapeutics, Inc. | General Manager, Europe | Form 4 sale | 15,000 | $300k | 100.0% | Unusual | SEC |